IP Library › Assignment 045252/0870
Patent Assignment
Reel/Frame 045252/0870

Assignment of Assignor's Interest

Recorded: 2018-02-05 Pages: 25
Assignor
EUTHYMICS BIOSCIENCE, INC.
Executed: 2017-10-31
Assignee
ETHISMOS RESEARCH, INC.
CAMBRIDGE INNOVATION CENTER, 1 BROADWAY, 14TH FLOOR, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties (65)
Novel Polymorphs of Azabicyclohexane
Process for the Synthesis of (+) and (-) -1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
Novel Arylbicyclo[3.1.0]Hexylamines and Methods and Compositions for Their Preparation and Use
Novel 1- Heteroaryl-3-Azabicyclo[3.1.0]Hexanes, Methods for Their Preparation and Their Use as Medicaments
Preparation and Use of (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane in the Treatment of Conditions Affected by Monoamine Neurotransmitters
Use of (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo{3.1.0}Hexane to Treat Addictive and Alcohol- Related Disorders
Novel Methods
(+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane, Compositions Thereof, and Uses as an Anti-Depressant Agent
Patent: 6,372,919 →
Application: 09/758,883 →
(+)-1-(3,4-Dichlorrophenyl)-3-Azabicyclo[3.1.0]Hexane, Compositions and Uses Thereof
Patent: 7,098,229 →
Application: 10/466,457 →
Publication: US 2004/0132797
Novel polymorphs of azabicyclohexane
Application: 11/205,956 →
Publication: US 2007/0043100
(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof
Application: 11/442,743 →
Methods and compositions for controlling body weight and appetite
Application: 11/603,974 →
Publication: US 2007/0225351
Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
Application: 11/740,667 →
Publication: US 2008/0045725
Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use
Application: 11/936,007 →
Publication: US 2008/0269348
Novel Arylbicyclo[3.1.0]Hexylamines and Methods and Compositions for Their Preparation and Use
Patent: 8,138,377 →
Application: 11/936,016 →
Publication: US 2008/0293822
Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use
Application: 11/936,722 →
Publication: US 2008/0194696
Methods And Compositions For Controlling Body Weight And Appetite
Application: 11/943,552 →
Publication: US 2008/0234354
Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes, Methods For Their Preparation And Their Use As Medicaments
Application: 12/135,053 →
Publication: US 2009/0069374
Novel Polymorphs of Azabicyclohexane
Application: 12/208,284 →
Novel Polymorphs of Azabicyclohexane
Application: 12/428,399 →
Publication: US 2009/0326245
Process For The Synthesis Of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
Application: 12/782,705 →
Publication: US 2010/0298574
Novel Polymorphs Of Azabicyclohexane
Application: 13/207,144 →
Publication: US 2011/0294847
Process For The Synthesis Of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
Application: 13/207,279 →
Publication: US 2011/0295020
Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes Methods For Their Preparation And Their Use As Medicaments
Application: 13/221,892 →
Methods And Compositions For Controlling Body Weight And Appetite
Application: 13/297,452 →
Preparation and Use of (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane In The Treatment of Conditions Affected by Monoamine Neurotransmitters
Application: 13/310,694 →
Publication: US 2012/0258994
USE OF (+)-1-(3,4-DlCHLOROPHENYL)-3-AZABICYCLO[3.1.0]HEXANE TO TREAT ADDICTIVE AND ALCOHOL-RELATED DISORDERS
Application: 13/335,981 →
Novel Polymorphs Of Azabicyclohexane
Patent: 8,765,801 →
Application: 13/366,209 →
Publication: US 2012/0136038
Process For The Synthesis Of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicycle[3.1.0]Hexane
Application: 13/366,211 →
Publication: US 2012/0142940
Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes, Methods For Their Preparation And Their Use As Medicaments
Application: 13/425,371 →
Use of (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane to treat addictive and alcohol-related disorders
Application: 13/507,610 →
Publication: US 2013/0123238
Methods For Inhibiting Native And Promiscuous Uptake Of Monoamine Neurotransmitters
Application: 13/605,890 →
Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes Methods For Their Preparation And Their Use As Medicaments
Application: 13/669,438 →
Methods For Inhibiting Native And Promiscuous Update Of Monoamine Neurotransmitters
Application: 13/764,520 →
Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes, Methods For Their Preparation And Their Use As Medicaments
Patent: 9,133,159 →
Application: 13/856,431 →
Publication: US 2014/0303207
Novel Polymorphs of Azabicyclohexane
Patent: 9,139,521 →
Application: 13/907,809 →
Publication: US 2013/0345279
Methods For Inhibiting Native And Promiscuous Uptake Of Monoamine Neurotransmitters
Application: 13/907,948 →
Publication: US 2014/0228421
Preparation and Use of (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane in the Treatment of Conditions Affected by Monoamine Neurotransmitters
Application: 13/923,016 →
Publication: US 2014/0039029
Process for the Synthesis of (+) and (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
Patent: 9,527,813 →
Application: 13/945,605 →
Publication: US 2014/0163240
Use of Amitifadine, (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane in Methods and Compositions with Enhanced Efficacy and Reduced Metabolic Side Effects and Toxicity for Treatment of Depression and Other Central Nervous System Disorders and Conditions Affected by Monoamine Neurotransmitters
Application: 13/964,024 →
Publication: US 2016/0346249
Use of (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane to Treat Addictive Disorders Including Nicotine Addiction
Application: 13/964,033 →
Use of (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane to Treat Addictive and Alcohol-Related Disorders
Application: 14/170,290 →
Publication: US 2014/0315892
Novel Combinations and Methods
Patent: 9,566,264 →
Application: 14/321,635 →
Publication: US 2015/0005359
Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes, Methods for Their Preparation and Their Use as Medicaments
Patent: 9,597,315 →
Application: 14/802,802 →
Publication: US 2016/0022634
Methods for Inhibiting Native and Promiscuous Uptake of Monoamine Neurotransmitters
Application: 14/853,910 →
Publication: US 2016/0199347
Novel Polymorphs of Azabicyclohexane
Patent: 9,770,436 →
Application: 14/860,427 →
Publication: US 2016/0008324
Use of (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane to Treat Addictive and Alcohol-Related Disorders
Application: 15/257,731 →
Publication: US 2017/0216251
Use of (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane to Treat Addictive Disorders Including Nicotine Addiction
Application: 15/257,756 →
Publication: US 2017/0209415
Process for the Synthesis of (+) and (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
Application: 15/367,718 →
Publication: US 2017/0233333
Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes, Methods for Their Preparation and Their Use as Medicaments
Application: 15/420,961 →
Publication: US 2017/0204088
Methods for Inhibiting Native and Promiscuous Uptake of Monoamine Neurotransmitters
Application: 15/699,423 →
Publication: US 2018/0215710
Preparation and Use of (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane in the Treatment of Conditions Affected by Monoamine Neurotransmitters
Application: 15/783,596 →
Publication: US 2018/0256542
Use of (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane to Treat Addictive and Alcohol-Related Disorders
Application: 15/813,703 →
Publication: US 2018/0296527
Process for the Synthesis of (+) and (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
Application: 15/820,959 →
Publication: US 2018/0319738
Novel polymorphs of azabicyclohexane
Application: 60/651,505 →
Process for the synthesis of (+) and (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane
Application: 60/796,097 →
Novel arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use
Application: 60/857,667 →
Novel 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
Application: 60/933,631 →
Preparation And Use Of (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters
Application: 61/419,769 →
Methods for inhibiting native and promiscuous uptake of monoamine neurotransmitters
Application: 61/573,499 →
USE OF (+)-1-(3,4-DlCHLOROPHENYL)-3-AZABICYCLO[3.1.0]HEXANE TO TREAT ADDICTIVE DISORDERS INCLUDING NICOTINE ADDICTION
Application: 61/682,314 →
Use of Amitifadine, (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane, in Methods and Compositions With Enhanced Efficacy and Reduced Metabolic Side Effects and Toxicity for Treatment of Depression and Other Central Nervous System Disorders and Conditions Affected by Monoamine Neurotransmitters
Application: 61/682,315 →
Novel Combinations and Methods
Application: 61/841,924 →
Novel Methods
Application: 61/902,762 →
Novel Methods
Application: 62/077,107 →
Related Assignments (21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 11, 2001
From: LIPPA, ARNOLD STAN; EPSTEIN, JOSEPH WILLIAM
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 011472/0422 →
Assignment of Assignor's Interest Feb 10, 2004
From: LIPPA, ARNOLD S.; EPSTEIN, JOSEPH W.
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 014968/0610 →
Assignment of Assignor's Interest Jul 19, 2007
From: LIPPA, ARNOLD S.; EPSTEIN, JOSEPH W.; TIZZANO, JOSEPH P.; BASILE, ANTHONY
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 019578/0357 →
Assignment of Assignor's Interest Nov 26, 2007
From: SKOLNICK, PHIL; CHEN, ZHENGMING; YANG, JI
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 020150/0067 →
Assignment of Assignor's Interest Nov 26, 2007
From: SKOLNICK, PHIL; CHEN, ZHENGMING; YANG, JI
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 020150/0061 →
Assignment of Assignor's Interest Nov 30, 2007
From: SKOLNICK, PHIL; CHEN, ZHENGMING; YANG, JI
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 020183/0290 →
Assignment of Assignor's Interest Jun 17, 2008
From: SKOLNICK, PHIL; CHEN, ZHENGMING
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 021107/0104 →
Confirmatory License Oct 3, 2008
From: UNIVERSITY, PENNSYLVANIA STATE
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 021632/0975 →
Assignment of Assignor's Interest Dec 22, 2011
From: MCKINNEY, ANTHONY ALEXANDER; BYMASTER, FRANK; PISKORSKI, WALTER
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 027437/0665 →
Merger Dec 29, 2011
From: DOV PHARMACEUTICAL, INC.
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 027457/0641 →
Formation and Reorganization Agreement Dec 29, 2011
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 027464/0279 →
Assignment of Assignor's Interest Mar 1, 2012
From: MCKINNEY, ANTHONY ALEXANDER; BYMASTER, FRANK
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 027791/0889 →
Assignment of Assignor's Interest Feb 20, 2014
From: HAGEN, ERIC J.; HALLORAN, KEVIN
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 032260/0388 →
Change of Name Feb 20, 2014
From: DOV PHARMACEUTICAL, INC.
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 032260/0504 →
Change of Name Apr 25, 2014
From: DOV PHARMACEUTICAL, INC.
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 032761/0432 →
Assignment of Assignor's Interest Apr 25, 2014
From: MERCK & CO., INC.
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 032761/0137 →
Assignment of Assignor's Interest Apr 25, 2014
From: MURRY, JERRY A.; SIMMONS, BRYON; CORLEY, EDWARD G.; XU, FENG
To: MERCK & CO., INC.
Reel/Frame 032761/0001 →
Assignment of Assignor's Interest May 20, 2014
From: HAGEN, ERIC J.; HALLORAN, KEVIN
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 032934/0157 →
Assignment of Assignor's Interest May 20, 2014
From: HAGEN, ERIC J.; HALLORAN, KEVIN
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 032933/0993 →
Assignment of Assignor's Interest Oct 28, 2016
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 040512/0162 →
Assignment of Assignor's Interest Jan 26, 2017
From: NEUROVANCE, INC.
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 041098/0323 →